At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
01541 IMMUNEONCO-B
Market Closed 02-21 16:08:24
6.280
+0.340
+5.72%
High6.530
Low5.950
Vol15.54M
Open5.950
D1 Closing5.940
Amplitude9.76%
Mkt Cap2.56B
Tradable Cap2.40B
Total Shares407.00M
T/O98.25M
T/O Rate4.07%
Tradable Shares382.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
data is loading...
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Instil Bio Inc - Plans U.S. Trial of Syn-2510/Imm2510 in 2H 2025
Institutions along with retail investors who hold considerable shares inImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541) come under pressure; lose 11% of holdings value
ImmuneOnco Biopharmaceuticals Shanghai Inc is a China-based company mainly engaged in research and development of testing biotechnology. The Company's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The Company mainly operates its businesses in the domestic and overseas markets.